Clinical trials of platelet receptor inhibitors
Topol, E.J.; Plow, E.F.
Thrombosis and Haemostasis 70(1): 94-98
1993
ISSN/ISBN: 0340-6245 PMID: 8236122 Document Number: 418229
Document emailed within 1 workday
Related Documents
Dancey, J.E.; Schoenfeldt, M. 2003: Clinical trials referral resource. Current clinical trials of agents targeting epidermal growth factor receptor Oncology 17(6): 819; 826Hwang, S.B.; Lam, M.H.; Hsu, A.H. 1989: Characterization of platelet-activating factor (PAF) receptor by specific binding of [3H]L-659,989, a PAF receptor antagonist, to rabbit platelet membranes: possible multiple conformational states of a single type of PAF receptors Molecular Pharmacology 35(1): 48-58
Knighton, D.R.; Doucette, M.; Fiegel, V.D.; Ciresi, K.; Butler, E.; Austin, L. 1988: The use of platelet derived wound healing formula in human clinical trials Progress in Clinical and Biological Research 266: 319-329
David, J.L. 1987: Mode of action and clinical evaluation of platelet aggregation inhibitors Revue Medicale de Liege 42(10): 526-533
Richman, D.; Itri, L.; Johnson, M.F.; Eigo, J. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--active control (equivalence) trials Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S88
Christofferson, R. 1998: Angiogenesis inhibitors in advanced cancer. many current clinical trials show promising results Lakartidningen 95(20): 2349-2354
Bartorelli, A.L. 1998: Inhibitors of platelet receptors in the cardiac catheterization laboratory: from a biological chimera to a clinical reality Cardiologia 43(1): 7-8
Ferreira, R. 1992: First Course of cardiovascular clinical pharmacology. II. Adjuvant therapy to thrombolysis. Anticoagulants and platelet aggregation inhibitors Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 11(3): 261-264
Cheung, R. 2000: Living up to expectations? AT1-receptor blockers in clinical trials International Journal of Clinical Practice. Suppl 111: 25-28
Matos, L. 2003: New possibilities in clinical use of angiotensin Ii receptor inhibitors Orvosi Hetilap 144(49): 2419-2423
Lindemann, S.; Klingel, B.; Fisch, A.; Meyer, J.; Darius, H. 1999: Increased platelet sensitivity toward platelet inhibitors during physical exercise in patients with coronary artery disease Thrombosis Research 93(2): 51-59
Nyby, M.D.; Sasaki, M.; Ideguchi, Y.; Wynne, H.E.; Hori, M.T.; Berger, M.E.; Golub, M.S.; Brickman, A.S.; Tuck, M.L. 1996: Platelet lipoxygenase inhibitors attenuate thrombin- and thromboxane mimetic-induced intracellular calcium mobilization and platelet aggregation Journal of Pharmacology and Experimental Therapeutics 278(2): 503-509
Lietman, P.; Temple, R.; Harrington, M.; Peck, C. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--approaches to clinical trials design Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S27
Collen, D.; Lu, H.R.; Stassen, J.M.; Vreys, I.; Yasuda, T.; Bunting, S.; Gold, H.K. 1994: Antithrombotic effects and bleeding time prolongation with synthetic platelet GPIIb/IIIa inhibitors in animal models of platelet-mediated thrombosis Thrombosis and Haemostasis 71(1): 95-102
Pöch, G.; Londong, W. 1985: Simple approach to assess potentiated drug combinations in clinical trials: studies with pirenzepine plus H2-receptor antagonists International Journal of Clinical Pharmacology Therapy and Toxicology 23(6): 283-287
Verburg, A.F.E.; van den Donk, M.; Wiersma, T. 2019: Application of new glucose lowering drugs: DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors Nederlands Tijdschrift Voor Geneeskunde 163
Davis, T.; Gore-Langton, R.E.; Cheson, B.D. 2000: Clinical trials referral resource. Current clinical trials of the anti-CD20 monoclonal antibody rituximab Oncology 14(10): 1437; 1440-1443
Baldini, C.; Delle Sedie, A.; Bombardieri, S. 2005: From clinical trials to the bedside: how can we treat patients with rheumatoid arthritis and concurrent morbidities who are generally excluded from randomised controlled clinical trials? Clinical and Experimental Rheumatology 23(6): 893-904
Trimble, E.L.; Rowland, J.; Varricchio, C.; Gore-Langton, R.E. 2001: Clinical trials referral resource. Health-related quality of life in cancer clinical trials Oncology 15(5): 601
Davis, T.; Schoenfeldt, M. 2004: Clinical trials referral resource. Current phase IIi clinical trials for adults with leukemia or lymphoma Oncology 18(1): 62; 65, 69